Back
Genfit SA Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison
Buy
56
GNFT
Genfit SA
Last Price:
4.54
Seasonality Move:
19.97%
Sell
15
ADAP
Adaptimmune Therapeutics PLC
Last Price:
0.59
Seasonality Move:
35.83%
Buy
56
Genfit SA (GNFT)
is a Buy
Is Genfit SA a Buy, Sell or Hold?
- The current Genfit SA [GNFT] share price is $5.21. The Score for GNFT is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- GNFT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
15
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?
- The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.77. The Score for ADAP is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
- ADAP is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
ADAP Stock Price Chart
What is Adaptimmune Therapeutics PLC's stock price today?
-
The Adaptimmune Therapeutics PLC share price today is $0.77
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing slight selling pressure.
GNFT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 41.02 | Sell |
| Chaikin Money Flow: | 1102 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.41 - 5.99) | Sell |
| Bollinger Bands (100): | (3.98 - 5.44) | Buy |
ADAP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 41.2 | Sell |
| Chaikin Money Flow: | -836750 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.74 - 0.86) | Sell |
| Bollinger Bands (100): | (0.85 - 1.21) | Sell |
GNFT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.47 | Sell |
| 20-day SMA: | 5.66 | Sell |
| 50-day SMA: | 5.25 | Sell |
| 200-day SMA: | 4.31 | Buy |
| 8-day EMA: | 5.4 | Sell |
| 20-day EMA: | 5.52 | Sell |
| 50-day EMA: | 5.29 | Sell |
| 200-day EMA: | 4.52 | Buy |
ADAP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.8 | Sell |
| 20-day SMA: | 0.79 | Sell |
| 50-day SMA: | 0.91 | Sell |
| 200-day SMA: | 1.13 | Sell |
| 8-day EMA: | 0.79 | Sell |
| 20-day EMA: | 0.81 | Sell |
| 50-day EMA: | 0.89 | Sell |
| 200-day EMA: | 1.02 | Sell |
Genfit SA Earnings Growth & GNFT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.88 per share, and a decrease next year of $1.55 per share.
Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and a decrease next year of $0.34 per share.
Genfit SA Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Adaptimmune Therapeutics PLC Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||